Steve Holloway[email protected]Artificial IntelligenceWhat were the main technology trends at RSNA 2022?There's no better economic barometer for the global medical imaging sector than the vast exhibition halls at the RSNA meeting. Industry guru Steve Holloway was in Chicago, and he reflects on the most important take-home messages.December 14, 2022Clinical NewsWill new growth stem from the 1B euro Affidea deal?The acquisition of imaging operator Affidea by Belgian investment firm Groupe Bruxelles Lambert reveals much about the future shape of radiology and the major market trends, but can the growth continue and where are the key opportunities? Industry analyst Steve Holloway has the answers.April 25, 2022Clinical NewsIrish cyberattack provides wake-up call for European imaging ITThe Irish attack shows that radiology providers can no longer bury their heads in the sand when it comes to cybersecurity. The hackers threaten the very core of a health system's function and purpose, writes market analyst Steve Holloway. What can be done? What lessons can be drawn?May 24, 2021Market AnalysisWhat impact will Brexit deal have on radiology?The protracted political, economic, and regulatory game of chess played by London and Brussels finally came to an end when the U.K. and European Union's Trade and Cooperation Agreement was signed on 24 December. Market columnist Steve Holloway assesses the implications of the Brexit deal.January 4, 2021Radiation Oncology/TherapyWhy Siemens, Varian deal is a win-win for both companiesNews of the deal between Siemens Healthineers and Varian Medical Systems will have caught many industry onlookers off guard on Sunday evening. In a new analysis, Stephen Holloway of Signify Research explains why the deal is a great fit for both companies.August 5, 2020Artificial IntelligenceCOVID-19: Early signs of recovery, but uncertainty aheadThe global pandemic has created an unprecedented shock to the medical imaging and healthcare sectors. What is the future likely to hold? What are the key economic trends, bright spots, and areas of greatest risk? Market columnist Steve Holloway investigates.June 10, 2020Market AnalysisWhy EMRs will not replace imaging ITDoes the rapid growth of electronic medical records (EMRs) mean that specialist software like PACS is heading toward extinction? Not so fast, according to Steve Holloway of Signify Research. Hospitals are finding there is still a role for imaging IT, despite EMRs' rise to prominence.October 20, 2019Industry NewsMamma Mia! What's the secret to Sectra's success?Sectra's strong performance in the global imaging IT market has attracted attention. Our market columnist Stephen Holloway takes a close look at the Swedish company's strategy and approach, and asks whether its success will continue.September 9, 2019Industry NewsWhat's really happening with enterprise imaging?For years now, experts have predicted that enterprise imaging would transform radiology, but in reality global adoption remains relatively low. Industry analyst Stephen Holloway presents his four key trends and observations from the recent Society for Imaging Informatics in Medicine annual meeting in Denver, Colorado, U.S.July 24, 2019Artificial IntelligenceEurope seeks progress on adoption of enterprise ITAs the shift to interdisciplinary care, centralized procurement, and artificial intelligence intensifies, radiology may fall behind if it fails to address significant IT challenges, particularly the approach to software adoption, writes market columnist Stephen Holloway.March 24, 2019Page 1 of 5Next PageTop StoriesMolecular ImagingDublin team evaluates radiation dose in PSMA PET/CTReducing average injected dose and uptake time in prostate-specific membrane antigen (PSMA) PET/CT can lead to improved patient throughput, according to Irish researchers.CTBelgium moves ahead with novel radiology referral schemeCTAssessing CT image quality: Which method is best?CTCT pearls from Ireland’s top orthopedic hospitalMolecular ImagingSPECT/CT identifies prostate cancer patients with poor outcomes
